Purple Biotech Ltd.
PPBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -0.1% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -10,150.5% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -10.2% | – | – |
| EPS Diluted | -4.42 | -0.16 | -0.23 | -0.21 |
| % Growth | -2,662.5% | 30.4% | -9.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |